These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1327813)

  • 1. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.
    Sofuoglu M; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1992 Jun; 216(2):273-7. PubMed ID: 1327813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of delta-opioid in NG108-15 cells.
    Ho BY; Holmes BB; Zhao J; Fujimoto J
    Eur J Pharmacol; 1997 Jan; 319(1):109-14. PubMed ID: 9030905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding profiles of delta-opioid receptor in human cerebral cortex membranes: evidence of delta-opioid receptor heterogeneity.
    Kim KW; Kim SJ; Shin BS; Choi HY
    Life Sci; 2001 Feb; 68(14):1649-56. PubMed ID: 11263677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antagonism by naltrindole-5'-isothiocyanate on [3H]DSLET and [3H]DPDPE binding to striatal slices of mice.
    Chakrabarti S; Sultana M; Portoghese PS; Takemori AE
    Life Sci; 1993; 53(23):1761-5. PubMed ID: 8246672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
    Sofuoglu M; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
    Crook TJ; Kitchen I; Hill RG
    Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat.
    Tiseo PJ; Yaksh TL
    Eur J Pharmacol; 1993 May; 236(1):89-96. PubMed ID: 8391455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA; Houghten R; Pasternak GW
    Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
    J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia.
    Shah S; Davis T; Yoburn BC
    Life Sci; 1994; 55(19):1451-8. PubMed ID: 7968211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal development of delta-opioid receptor subtypes in mice.
    Negri L; Severini C; Lattanzi R; Potenza RL; Melchiorri P
    Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
    Tao PL; Tsai CL; Chang LR; Loh HH
    Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.
    Barrett RW; Vaught JL
    Life Sci; 1983 Dec; 33(24):2439-48. PubMed ID: 6316063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ; Bian JT; Bhargava HN
    Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative binding properties of linear and cyclic delta-selective enkephalin analogues: [3H]-[D-Thr2, Leu5] enkephalyl-Thr6 and [3H]-[D-Pen2, D-Pen5] enkephalin.
    Delay-Goyet P; Zajac JM; Rigaudy P; Foucaud B; Roques BP
    FEBS Lett; 1985 Apr; 183(2):439-43. PubMed ID: 2985440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity.
    Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
    Peptides; 1993; 14(5):893-907. PubMed ID: 8284266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes.
    Portoghese PS; Sultana M; Nelson WL; Klein P; Takemori AE
    J Med Chem; 1992 Oct; 35(22):4086-91. PubMed ID: 1331455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.